|
|
||||||||
Ann Thorac Surg 1998;66:187-192
© 1998 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, University of Missouri Hospital and Clinics, Columbia, Missouri, USA
b Department of Surgery, University of Maryland Hospital, Baltimore, Maryland, USA
c Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
d Department of Surgery, Long Island Jewish Medical Center, Long Island, New York, USA
e Department of Surgery, State University of New York at Syracuse, Syracuse, New York, USA
f Department of Surgery, Brigham & Womens Hospital, Boston, Massachusetts, USA
g Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
Address reprint requests to Dr Demmy, Division of Cardiothoracic Surgery, University of Missouri, 245 Major Hall, Dc119.0, Columbia, MO 65212
Presented at the Forty-fourth Annual Meeting of the Southern Thoracic Surgical Association, Naples, FL, Nov 68, 1997.
| Abstract |
|---|
|
|
|---|
Methods. We studied 48 cases from Cancer and Leukemia Group B thoracic surgeons. Of 21 men and 27 women, aged 41 ± 16 years, 22 patients were asymptomatic. In the others, 92% of tumor-related symptoms improved or resolved after treatment. Five tumors involved the anterior compartment, 19 the middle, and 24 the posterior compartment. Diagnoses were typical for each compartment but also included uncommon problems such as superior vena cava hemangioma and a histoplasmosis cyst causing hoarseness. Of the lesions, a biopsy of 12 was done without excision and the rest were excised completely. Fifteen were cystic and 10 were malignant (8 biopsy only). Maximal dimensions were 5.2 ± 3.3 cm.
Results. Operations were briefer for 24 posterior (93 ± 41 min) than 5 anterior (195 ± 46 min, p < 0.01) or 19 middle mediastinal tumors (170 ± 78 min, p < 0.01). Although 96% had vital mediastinal relations, only six open conversions were performed because of bleeding (n = 3), large size, impaired exposure, or rib attachments, and no patient had morbidity beyond that expected for the thoracotomy. Postoperative stay was shorter for the nonconversion group (3.2 ± 2.8 versus 5.5 ± 2.1 days, p = 0.05), as was chest tube duration (1.7 ± 1.4 days versus 3.2 ± 1.9 days, p = 0.03). There were no postoperative deaths or major complications, but 7 patients had minor complications. During a mean of 20 months of surveillance (range, 1 to 52 months), one cyst recurred (asymptomatic) as did one sarcoma that was excised.
Conclusions. Video-assisted thoracic surgery is a safe technique for benign mediastinal tumors, typically those in the middle and posterior mediastinum.
| Introduction |
|---|
|
|
|---|
| Material and methods |
|---|
|
|
|---|
After induction of general anesthesia, single lung ventilation was performed, and a pneumothorax was created on the operative side. Dual lumen endobronchial tubes were used for selective ventilation, and occasionally bronchus blockers were used for left lung procedures. One institution used CO2 gas insufflation (<10 mm Hg using 3 L/min flow) to collapse the lung. The patients were positioned in the lateral decubitus position. A 0° or 30° video telescopic camera was inserted through a port at the midaxillary line in the lower chest (eighth to ninth intercostal space). This allowed internal visualization during creation of thoracoscopy ports at the anterior and posterior axillary lines in the fifth or sixth intercostal spaces.
All cases generally required 2 working ports (10 mm or greater) in addition to the camera port. Complicated dissection occasionally used 1 to 2 additional 5-mm ports. More detailed port data were not collected for this study. For tumors in the anterosuperior mediastinum, the patients arms were extended over their heads and the ports positioned more anteriorly and apically for better visualization. The dissections were performed either with endoscopic port instruments or standard instruments introduced directly through the chest wall. Sharp and blunt dissection techniques were used to separate tumors from the surrounding organs. Cautery provided hemostasis in areas distant from sensitive structures such as the phrenic nerve. In all but 2 cyst excisions, the cavities were opened and aspirated during their dissection to facilitate removal. In 3 cases, when a cyst was too densely adherent to a vascular or other vital structure (Fig 1A), the nonadherent portion of the cyst was excised and the remaining cyst wall cauterized if lined by epithelium. For all solid masses that could contaminate the chest wall, the working port incisions were extended as needed to accomplish delivery of specimens within extraction sacs.
|
| Results |
|---|
|
|
|---|
|
Specific pathologic diagnoses for each mediastinal compartment are listed in Table 1. Overall maximal dimensions of the lesion were 5.2 ± 3.3 cm. Symptoms were common in patients with malignancy (70%); however, symptoms were not significantly different than the 50% incidence of symptoms in patients with benign disease. Patients with symptoms had larger masses (6.4 ± 3.7 versus 3.6 ± 2.1 cm; p < 0.01). The presence of symptoms was associated with a longer hospital stay (4.3 ± 3.3 versus 2.6 ± 1.8 days; p = 0.03), and longer chest tube drainage (2.3 ± 1.7 versus 1.5 ± 1.2 days; p = 0.05). One patient had an unusual symptom for benign disease, namely, hoarseness from a laryngoscopically verified right vocal cord paresis. The patients hoarseness resolved immediately after drainage of a mediastinal histoplasmoma cyst (Fig 1B). Remarkable physical findings were absent in this study except for 2 patients with mediastinal malignancy. One had muscle wasting and the other mild neck vein engorgement from the mediastinal tumor.
|
Six patients required conversion to thoracotomy, 1 of whom had a rare venous hemangioma of the superior vena cava. Figure 1C shows the computed tomographic findings of this unusual tumor with phleboliths within this mass. The mass was dissected until a 1-cm stalk remained attached to the superior vena cava. A small tear in the superior vena cava occurred while applying vascular clips to the stalk. Bleeding was controlled by occluding the tear while a thoracotomy was performed to complete the excision above a partial exclusion vascular clamp. Two other patients required conversion to thoracotomy for optimal control of bleeding during attempted VATS excisions: 1 from extensive tumor vascularity in a paraganglioma and 1 from an intercostal vessel in a bronchogenic cyst. The other 3 conversions were to improve exposure during excision of a large anterior germ cell tumor, an esophageal leiomyoma, and a metastatic adenocarcinoma nodule adherent to the esophagus. The conversion group required a similar total operating time (178 ± 112 versus 129 ± 61 minutes; p > 0.1) and received no transfusions. One case of pneumonia and 1 postoperative chylothorax were treated in the converted group, and neither patient remained hospitalized for longer than 8 days. Nevertheless, postoperative stay was longer for the conversion group (5.5 ± 2.1 versus 3.2 ± 2.8 days; p = 0.05), as was chest tube duration (3.2 ± 1.9 versus 1.7 ± 1.4 days; p = 0.03).
There were no operative or hospital deaths in this study and no patients had a major complication. For all patients, the mean chest tube duration was 1.9 ± 1.5 days and the mean postoperative stay was 3.5 ± 2.8 days and reflects the inclusion of time in which some patients remained in the hospital for chemotherapy. Seven minor complications occurred, including a 4-day pleural air leak, ileus, superficial wound infection, and severe perioperative pain (1 each). One pneumothorax and 1 pleural effusion responded to thoracentesis, and 1 case of Horner syndrome resolved by 3 months. By the first 2- to 6-week postoperative) clinic visit, all patients with benign disease and VATS alone had returned to work or their preoperative activity except for the patient who noted mild exercise limitation from a pleural effusion that later resolved.
Postdismissal data were available for 92% of patients, with an average follow-up time of 20 ± 18 months (range, 1 to 52 months). The proportion of patients reporting return to full preoperative activity was 33% by 2 weeks, 50% by 3 weeks, and 80% by 4 weeks. Most of the remaining patients had been converted to thoracotomy or had their convalescence delayed by treatments such as chemotherapy. The average times of follow up were briefer for posterior compartment operations (12.8 ± 15.2 months) than anterior (24.5 ± 24.4 months, p = not significant) or middle mediastinal tumors (27.5 ± 18.2 months, p < 0.01) because 70% of the lesions in the last 30 months of the study were in the posterior compartment compared with 35% from the first 30 months (Fig 2).
|
| Comment |
|---|
|
|
|---|
In this study, which is comparable with other favorable reports detailing the use of thoracoscopy for mediastinal cysts, we found a ratio of cystic to solid tumors similar to that found in other series [1, 47]. There were no early complications using the technique of cyst drainage followed by complete or nearly complete excision. Other investigators found that a portion of the cyst wall can be left behind provided its lining is nonsecretory or is rendered inactive by cautery or other means [5]. In this study, however, one cyst recurred, suggesting this compromise may need future study. Two pericardial cysts were resected. One was large and symptomatic and another required operation for diagnosis because of its unusual radiographic appearance.
The ratio of benign to malignant lesions in this series (4:1) is greater than that in reports of open resections of mediastinal tumors (3:2) [4, 7]. This finding is not surprising because lesions that appear malignant would be less likely to be treated using a VATS technique. Because the anterior compartment has the largest proportion of malignant tumors, there are few anterior mediastinal masses in this series (10%) although this mediastinal tumor location is the most common (50% to 60% in most series) [79]. Therefore, thoracoscopic resections of mediastinal neoplasms, particularly those in the anterior compartment, need to be evaluated cautiously [10]. Furthermore, the excellent exposure afforded by the relatively well tolerated median sternotomy has limited the growth of the VATS procedure for anterior mediastinal masses.
The limitations of VATS technology may compromise the results of resectional treatment of mediastinal neoplasms. For instance, disruption of thymomas during VATS dissection could lead to pleural and chest wall implants, which have been reported in other techniques [11]. Reports of early local cancer recurrence after thoracoscopic resection of indeterminant pulmonary nodules have led to routine encasing of specimens before extraction [12]. We endorse this practice for mediastinal mass extractions as well, regardless of whether it is an incisional biopsy or a partial or complete resection.
Despite the effort to maximize accuracy, this study is limited by lack of prospective data collection and a contemporary comparison group. Unfortunately, a controlled trial is probably not possible given the unusual and varied nature of mediastinal tumors. Compared with operations that require thoracotomy, the postoperative lengths of stay and times to return to work or full home activity were favorable. Although the operative times seem longer than expected for open resection of middle and anterior tumors, the overall cost of an uncomplicated minimally invasive mediastinal mass excision may be less than that of an open operation. Much of the expensive disposable instrumentation that reduced cost savings in other VATS procedures is not needed for these operations [13]. Although not measured directly in this study, the reduced disposable costs along with the observed reduction in postoperative hospital stay should offset longer operative times and make VATS excision a cost-effective option.
On the basis of our experience, the decision to treat a mediastinal lesion by VATS is based on whether exposure and dissection can proceed in a fashion similar to an open operation. This decision requires careful assessment of lesion location, proper port placement, and prerequisite experience with VATS. The learning curve is improved by increasing operator experience as well as evolving imaging and instrument technology [14]. There should be a low threshold to improve exposure by use of a limited or standard thoracotomy, especially when risks increase for tumor dissemination or hemorrhage.
It is appropriate to consider all thin-wall mediastinal cysts for VATS resection because they can be decompressed and delivered through a small port. The results have been uniformly good for this therapy [4, 5]. Occasionally, portions of the cyst wall intimately related to vital structures will be left behind and cauterized in both VATS and open procedures. Small solid masses are appropriate for minimally invasive resection, particularly those with low risk by virtue of known benign histologic characteristics, slow growth, encapsulation, posterior compartment location, and lack of invasion or neovascularity by imaging studies or thoracoscopic inspection.
Neoplastic or potentially malignant masses are approached by VATS largely for assessment of staging, planning open resection, or incisional biopsy. The last procedure is reserved for patients whose prognoses are unaltered by possible contamination of the pleural space by tumor, such as those with solid malignancies of documented advanced stage or nonsurgical hematologic malignancies such as lymphoma. Because this criterion was used, no patient in this series who underwent incisional biopsy manifested local recurrence. Video-assisted thoracic surgery provides a larger tissue sample for accurate histologic classification of presumed lymphomas than do simpler techniques such as computed tomographic-directed core biopsies. The need to access multiple areas, tumors remote from mediastinoscopy or mediastinotomy approaches, and high-risk anatomic tumor relations (eg, aorta) may also favor the exposure afforded by thoracoscopy. Considerable dissection is required to resect areas of potential intrathoracic invasion, ie, chest wall, to obtain margins free of tumor. This makes minimally invasive techniques less relevant and accounts for our limited experience and few reports from others. For patients with mediastinal neoplasms treated best by resection and who can tolerate standard thoracotomy, we cannot yet support VATS other than for investigative purposes. More time is needed to determine whether resection of malignant tumors such as those in this study results in findings similar to those of open resection. The case of nonmetastatic liposarcoma in this series had excellent exposure and its posterior attachments were dissected in a manner comparable with open thoracotomy. The follow-up of this case is still very short.
Several unusual patients were included in this multicenter experience. One patient had a venous hemangioma of the superior vena cava, which is rare [4]. The conversion to thoracotomy in this patient may have been avoided if subsequent technical innovations had been available at that time. For instance a longitudinally applied endoscopic vascular stapler would have better controlled the tumors stalk. The intercostal bleeder related to a bronchogenic cyst could have been controlled easily by cautery technology now available. The case of recurrent laryngeal nerve compromise by histoplasmosis is also quite rare [15]. Our patients hoarseness resolved after cyst excision, unlike the patient described by Gilbert and associates [15], in whom the hoarseness was permanent.
Video-assisted thoracic surgery appears to be a safe technique for the diagnosis and treatment of benign mediastinal tumors, particularly those in the middle and posterior mediastinum in carefully selected patients. The application of this technology for potentially resectable malignant mediastinal masses should be limited to an investigative setting until its safety and oncologic validity can be verified.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. J. Kohman Cancer and leukemia group B surgery committee. Clin. Cancer Res., June 1, 2006; 12(11): 3622s - 3627s. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sasaki, S. Hirai, M. Kawabe, T. Uesaka, K. Morioka, A. Ihaya, and K. Tanaka Triangle target principle for the placement of trocars during video-assisted thoracic surgery Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 307 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bodner, H. Wykypiel, A. Greiner, W. Kirchmayr, M. C. Freund, R. Margreiter, and T. Schmid Early experience with robot-assisted surgery for mediastinal masses Ann. Thorac. Surg., July 1, 2004; 78(1): 259 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Reed General thoracic surgery and the Southern Thoracic Surgical Association: the second 25 years Ann. Thorac. Surg., November 1, 2003; 76(90050): S14 - 16. [Full Text] [PDF] |
||||
![]() |
S.-F. Ko, S.-H. Ng, M.-J. Hsieh, J.-W. Lin, C.-C. Huang, T.-Y. Lee, and W.-J. Chen Castleman disease of the pleura: experience with eight surgically proven cases Ann. Thorac. Surg., July 1, 2003; 76(1): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takeda, S. Miyoshi, M. Minami, M. Ohta, A. Masaoka, and H. Matsuda Clinical Spectrum of Mediastinal Cysts Chest, July 1, 2003; 124(1): 125 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Seirafi, E. Ferguson, and F. H. Edwards Thoracoscopic Resection of Castleman Disease: Case Report and Review Chest, January 1, 2003; 123(1): 280 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shimokawa, S.-i. Watanabe, K.-i. Sakasegawa, and A. Tani Ruptured thymoma causing mediastinal hemorrhage resected via partial sternotomy Ann. Thorac. Surg., January 1, 2001; 71(1): 370 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karajiannis, T. Krueger, E. Stauffer, and H.-B. Ris Large thoracic duct cyst - a case report and review of the literature Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 754 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. I. Cirino, J. R. Milanez de Campos, A. Fernandez, M. N. Samano, P. P. Fernandez, L. T. B. Filomeno, and F. B. Jatene Diagnosis and Treatment of Mediastinal Tumors by Thoracoscopy Chest, June 1, 2000; 117(6): 1787 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Porte, D. Metois, L. Finzi, G. Lebuffe, A. Guidat, M. Conti, and A. Wurtz Superior vena cava syndrome of malignant origin. Which surgical procedure for which diagnosis? Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 384 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Colt Thoracoscopy: Window to the Pleural Space Chest, November 1, 1999; 116(5): 1409 - 1415. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |